Dodge R - Search Results

1

Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer.

Olt G, Soper J, Ramakrishnan S, Xu F, Berchuck A, Clarke-Pearson D, Dodge R, Bast RC Jr. Olt G, et al. Among authors: dodge r. Am J Obstet Gynecol. 1996 Apr;174(4):1316-9. doi: 10.1016/s0002-9378(96)70678-6. Am J Obstet Gynecol. 1996. PMID: 8623863

2

Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging.

Soper JT, Berchuck A, Dodge R, Clarke-Pearson DL. Soper JT, et al. Among authors: dodge r. Obstet Gynecol. 1992 Jun;79(6):993-7. Obstet Gynecol. 1992. PMID: 1579329

3

Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma.

Berchuck A, Anspach C, Evans AC, Soper JT, Rodriguez GC, Dodge R, Robboy S, Clarke-Pearson DL. Berchuck A, et al. Among authors: dodge r. Gynecol Oncol. 1995 Oct;59(1):20-4. doi: 10.1006/gyno.1995.1262. Gynecol Oncol. 1995. PMID: 7557610 Clinical Trial.

4

p53 overexpression in advanced-stage endometrial adenocarcinoma.

Kohler MF, Carney P, Dodge R, Soper JT, Clarke-Pearson DL, Marks JR, Berchuck A. Kohler MF, et al. Among authors: dodge r. Am J Obstet Gynecol. 1996 Nov;175(5):1246-52. doi: 10.1016/s0002-9378(96)70036-4. Am J Obstet Gynecol. 1996. PMID: 8942496

5

Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer.

Clifford SL, Kaminetsky CP, Cirisano FD, Dodge R, Soper JT, Clarke-Pearson DL, Berchuck A. Clifford SL, et al. Among authors: dodge r. Am J Obstet Gynecol. 1997 Jun;176(6):S229-32. doi: 10.1016/s0002-9378(97)70380-6. Am J Obstet Gynecol. 1997. PMID: 9215213

6

Overexpression and mutation of p53 in endometrial carcinoma.

Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC Jr, Marks JR. Kohler MF, et al. Among authors: dodge rk. Cancer Res. 1992 Mar 15;52(6):1622-7. Cancer Res. 1992. PMID: 1540970

7

Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease.

Berchuck A, Rodriguez G, Kinney RB, Soper JT, Dodge RK, Clarke-Pearson DL, Bast RC Jr. Berchuck A, et al. Among authors: dodge rk. Am J Obstet Gynecol. 1991 Jan;164(1 Pt 1):15-21. doi: 10.1016/0002-9378(91)90615-x. Am J Obstet Gynecol. 1991. PMID: 1670908

8

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancer.

Berchuck A, Rodriguez GC, Kamel A, Dodge RK, Soper JT, Clarke-Pearson DL, Bast RC Jr. Berchuck A, et al. Among authors: dodge rk. Am J Obstet Gynecol. 1991 Feb;164(2):669-74. doi: 10.1016/s0002-9378(11)80044-x. Am J Obstet Gynecol. 1991. PMID: 1992720

9

The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.

Rodriguez GC, Clarke-Pearson DL, Soper JT, Berchuck A, Synan I, Dodge RK. Rodriguez GC, et al. Among authors: dodge rk. Obstet Gynecol. 1994 Mar;83(3):445-8. Obstet Gynecol. 1994. PMID: 8127540

10

Interval to treatment in endometrial cancer.

Berchuck A, Dodge RK. Berchuck A, et al. Among authors: dodge rk. Am J Obstet Gynecol. 1993 Dec;169(6):1655-6. doi: 10.1016/0002-9378(93)90461-q. Am J Obstet Gynecol. 1993. PMID: 8267085 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

340 results

Search Page

Filters